Pharma Industry News

A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.

globenewswire.com - Nxera Pharma - Nxera Pharma Operational Highlights and Consolidated Results for the Second Quarter 2026
Nxera Pharma Operational Highlights and Consolidated Results for the Second Quarter 2026
GlobeNewswire

Tokyo, Japan and Cambridge, UK, 7 August 2026 – Nxera Pharma (“the Company” or “Nxera”; TSE: 4565) provides an update on operational activities and reports its consolidated results for the second quarter ended 30…

thehindu.com - Rajulapudi Srinivas - USFDA, DCA discuss ways to boost pharma manufacturing and drug quality in Andhra Pradesh
USFDA, DCA discuss ways to boost pharma manufacturing and drug quality in Andhra Pradesh
The Hindu

The officials of the Drug Control Administration (DCA) in Andhra Pradesh and U.S. Food and Drug Administration (USFDA) discussed ways to strengthen global regulatory collaboration and promote scientific pharmaceutical manufacturing at the…

siliconrepublic.com - Laura Varley - Rinn Pharma & Biopharma to join NordicPharmaTrain network
Rinn Pharma & Biopharma to join NordicPharmaTrain network
Silicon Republic

The partnership will significantly strengthen Ireland's position within the European pharmaceutical research and innovation space. Research Ireland's Rinn Pharma & Biopharma, which is Ireland's national centre for research and innovation in the…

thehindubusinessline.com - Medical device start-ups finding it challenging to sell their products, need industry partnerships to survive: Pharma Secretary Manoj Joshi
Medical device start-ups finding it challenging to sell their products, need industry partnerships to survive: Pharma Secretary Manoj Joshi
BusinessLine

Calling India's medical device start-up ecosystem vibrant but commercially fragile, Pharma Secretary Manoj Joshi on Friday said many start-ups are struggling to take their innovations to market despite receiving government support, and urged…

smh.com.au - Elias Visontay - 'Talk to your doctor': Pharma giants' weight loss ads skirt Australian law
'Talk to your doctor': Pharma giants' weight loss ads skirt Australian law
The Sydney Morning Herald

Health experts have hit out at the emergence of US-inspired ads spruiking prescription medicines, as pharma giants behind blockbuster weight loss drugs skirt local laws banning promotions of their products by encouraging Australians to proactively…

marketbeat.com - Q3 EPS Estimates for Urogen Pharma Lifted by HC Wainwright
Q3 EPS Estimates for Urogen Pharma Lifted by HC Wainwright
MarketBeat

3 Bullish Biotech Stocks With Explosive Growth Trends Urogen Pharma (NASDAQ:URGN - Free Report) - Investment analysts at HC Wainwright upped their Q3 2027 earnings estimates for Urogen Pharma in a research note issued to investors on Thursday…

marketbeat.com - Ascentage Pharma Group International (NASDAQ:AAPG) Shares Gap Up - Time to Buy?
Ascentage Pharma Group International (NASDAQ:AAPG) Shares Gap Up - Time to Buy?
MarketBeat

Ascentage Pharma Group International - Unsponsored ADR (NASDAQ:AAPG - Get Free Report) gapped up prior to trading on Friday. The stock had previously closed at $16.85, but opened at $18.49. Ascentage Pharma Group International shares last traded at…

marketbeat.com - Ascendis Pharma A/S (NASDAQ:ASND) Receives Average Recommendation of 'Buy' from Analysts
Ascendis Pharma A/S (NASDAQ:ASND) Receives Average Recommendation of 'Buy' from Analysts
MarketBeat

Ascendis Pharma A/S (NASDAQ:ASND - Get Free Report) has been given an average rating of 'Buy' by the nineteen analysts that are currently covering the firm, Marketbeat reports. One research analyst has rated the stock with a hold rating, sixteen…

seekingalpha.com - Jonathan Weber - Novo Nordisk: The Market Has Lost Its Mind, Too Cheap To Ignore (NYSE:NVO)
Novo Nordisk: The Market Has Lost Its Mind, Too Cheap To Ignore (NYSE:NVO)
Seeking Alpha

Novo Nordisk A/S delivered a strong Q2, beating revenue by 10% and EPS by over 20%, yet shares dipped post-earnings. NVO's adjusted revenues rose 7% year-over-year, driven by international and obesity care growth, despite US pricing headwinds and…

marketbeat.com - Equities Analysts Offer Predictions for NAMS FY2027 Earnings
Equities Analysts Offer Predictions for NAMS FY2027 Earnings
MarketBeat

NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS - Free Report) - Equities research analysts at HC Wainwright lowered their FY2027 earnings per share (EPS) estimates for shares of NewAmsterdam Pharma in a research note issued to investors on Thursday…

newswire.ca - Vimy Pharma - Harmony Acquisitions Announces Proposed Qualifying Transaction with Vimy Pharmaceuticals
Harmony Acquisitions Announces Proposed Qualifying Transaction with Vimy Pharmaceuticals
CNW

VANCOUVER, BC, Aug. 6, 2026 /CNW/ -- Harmony Acquisitions Corp. (TSXV: MONY.P) ('Harmony' or the 'Company') and Vimy Pharmaceuticals Inc. ('Vimy Pharma') are pleased to announce that they have entered into a non-binding letter of intent dated…

cnbc.com - Tobias Burns - Shares of this digital medical platform were up more than 100% at one point. Here's what's driving it
Shares of this digital medical platform were up more than 100% at one point. Here's what's driving it
CNBC

Doximity had a solid first quarter and raised its full year revenue guidance. But AI search isn't baked into these forecasts, analysts believe, and it's bringing in 10 times the revenue it costs to run, the CEO revealed on the conference call. The…

seekingalpha.com - Albert Anthony - MetLife's Q2 Earnings Beat Reaffirms The Buy Case As Organic Growth Stands Out (NYSE:MET)
MetLife's Q2 Earnings Beat Reaffirms The Buy Case As Organic Growth Stands Out (NYSE:MET)
Seeking Alpha

Albert Anthony is the pen name of a business author on Amazon and his newest book is 'How To Pick Stocks: 8 Steps For Long-Term Investing with Fundamental & Technical Analysis,' now available as a 2026 edition paperback and Kindle ebook in several…

thehindubusinessline.com - Team BL - Stock Market Today Highlights, Aug 7: Sensex falls 456 points, Nifty slips as banking stocks drag markets lower
Stock Market Today Highlights, Aug 7: Sensex falls 456 points, Nifty slips as banking stocks drag markets lower
BusinessLine

Sensex Today, Nifty 50 | Stock Market Highlights: 7 August 2026. Indian benchmark indices closed lower on Friday, ending a two-day recovery, as weakness in banking and financial stocks combined with elevated crude oil prices and geopolitical…

semafor.com - Shelly Banjo - Novo Nordisk faces a rough patch
Novo Nordisk faces a rough patch
Semafor

Novo Nordisk's CFO has spent the last few days on the phone trying to reassure investors that the GLP-leader hasn't lost a step. The market isn't buying it. Novo's shares have fallen 15% this year, tumbling further this week after guidance missed…

Receive a Daily briefing on Pharma Industry News

Get Started